AEGiS-LT: AIDS Testing for Pregnant Women Urged - Health: An expert committee says voluntary screening should be offered in areas with high prevalence of the human immunodeficiency virus.

Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

AIDS Testing for Pregnant Women Urged - Health: An expert committee says voluntary screening should be offered in areas with high prevalence of the human immunodeficiency virus.

Los Angeles Times (LT) - WEDNESDAY January 16, 1991; Edition: Home Edition Page: 19 Pt. A Col. 1 Word Count: 499
MARLENE CIMONS; TIMES STAFF WRITER

WASHINGTON - The AIDS antibody test should be offered to all pregnant women who live in areas where there is a high prevalence of the deadly disease, an expert committee of the Institute of Medicine recommended Tuesday.

But such screening for infection with the human immunodeficiency virus should be strictly voluntary and only occur with written informed consent, said the committee, a part of the National Academy of Sciences.

Screening for pregnant women "can be an important health care tool" allowing early identification and treatment of HIV infection with drugs that have been shown to delay the onset of fully developed AIDS. Further, the information will enable women to make a "more informed decision" regarding reproduction, the committee said.

"Ultimately, the woman must decide whether to continue or terminate an existing pregnancy in the face of HIV infection," the panel said.

Of the 154,791 AIDS cases reported in the United States as of the end of November, 15,133 have occurred among women and 2,734 among children, according to the federal Centers for Disease Control.

More than 80% of the children with AIDS acquired the infection during gestation or at the time of delivery, the panel said. AIDS is expected to become one of the five leading causes of death among women of reproductive age if current trends continue, the CDC has said.

Because diagnosis of HIV infection "can have powerful psychological and social consequences," the committee emphasized that women should have the right to refuse to be tested.

"Prenatal HIV screening should not be mandatory because of the multitude of costs involved," said Dr. Marie C. McCormick, committee chairwoman and associate professor of pediatrics at the Harvard Medical School. "There are great psychological and social costs to women who test positive for HIV, including the threat of discrimination in health care, employment and access to housing."

The HIV antibody test "does not qualify as a benign, routine medical test that may be performed under the conditions of general or presumed consent," which is the case with many routine medical tests, the panel said in its report.

The National Academy of Sciences is a congressionally chartered, private organization that advises the federal government. The Institute of Medicine has previously issued several highly regarded reports that address responses to the decade-long AIDS epidemic. The panel recommended against routine testing of newborns, saying such screening "cannot be justified at present" because such tests are inconclusive in newborns.

The committee also opposed newborn screening on the grounds "that it is tantamount to involuntary maternal screening." "Using newborn HIV screening to identify HIV-infected mothers would also mean that postpartum women currently would be the only civilian, non-institutionalized adult population not given the opportunity to consent to or refuse HIV testing, an outcome that is ethically unacceptable," the panel said.

However, the committee strongly endorsed continued anonymous screening of newborns for research purposes.

This approach provides "unbiased epidemiological data for monitoring national and local trends in the distribution of HIV infection, particularly among childbearing women," the panel said.

Keywords: DIAGNOSTIC TESTS; WOMEN--HEALTH; ACQUIRED IMMUNE DEFICIENCY SYNDROME; PREGNANCY; INSTITUTE OF MEDICINE

910114
LT910114

Copyright © 1991 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .